acute myeloid leukemia (AML) | Page 3 | Aplastic Anemia & MDS International Foundation Return to top.

acute myeloid leukemia (AML)

Srinivas Tantravahi, MBBS, MRCP

Srinivas, Tantravahi
Hematologist
Huntsman Cancer Hospital

Dr. Tantravahi has received his medical degree from Guntur medical college, India. He then completed Internal Medicine residency and Hematology and Oncology fellowship training at University of Utah Hospital. His clinical interests include multiple myeloma, stem cell transplantation, and myeloproliferative neoplasm. Research interests are targeted therapy in CML and myeloproliferative neoplasms.

2023 Omaha Patient and Family Hybrid Conference

Here are the session recordings and the presentations for the 2023 Omaha Patient and Family Hybrid Conference.

Event Date: 
Sat, 04/15/2023 - 9:30am (EDT)
Conference Event Type: 

Updates from ASH22 on MDS and AML

In this webinar, Dr. Lourdes Mendez discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2022 meeting.  Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML. This is an advanced scientific presentation. The question and answer session is included in this recording.

Aplastic Anemia, MDS, and PNH Virtual Support Group - 2023 April

Event Date: 
Sat, 04/22/2023 - 10:30am (EDT)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Aplastic Anemia, MDS, and PNH Virtual Support Group - 2023 March

Event Date: 
Sat, 03/25/2023 - 10:30am (EDT)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Aplastic Anemia, MDS, and PNH Virtual Support Group - 2023 February

Event Date: 
Sat, 02/25/2023 - 10:30am (EST)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Share with addtoany.com.